A London-based writer specialising in healthcare policy in Southern Europe and Latin America; and former deputy editor and then investigations editor for the medical technology news service Clinica.
Drug regulators have noticed a proliferating problem. Around the world various regional regulators are applying different naming conventions for biosimilars.
Pharmacies in areas with high rates of hospital visits for asthma dispensed fewer preventive medicines compared with reliever drugs, US research has found.
A radical review of how insulin pumps are approved for use and then monitored once on the market is required, according to diabetes groups in United States and Europe.